How Can Medical Device Manufacturers Make Best Use Of Patient Preference Information?

There is a growing need for real-world-evidence (RWE) and patient perspectives when bringing new pharmaceuticals and medical technologies to market. An emerging metric in the RWE arena is patient preference information, which can provide  supplemental data that empowers device manufacturers to demonstrate value and meet expectations of regulators, payers, hospitals, and patients. As defined in the introduction to the case study, “Patient preference information captures the value that patients place on aspects of a treatment option, while also accounting for their perspectives on trade-offs they are willing to make for the benefits and risks that come with the treatment.”

More Like This

Case Study: Innovative Reimbursement Strategy for Digital Therapeutics

Real-World Clinical Evidence Generation: Advancing Regulatory Science and Patient Access for In Vitro Diagnostics (IVDs)

Top 10 Strategies: Unlocking US Market Access and Reimbursement for Emerging Medical Technologies